$SNTA Recent Headlines Buy stocks driven by se
Post# of 144798
Posted On: 06/08/2014 12:22:20 PM
$SNTA Recent Headlines
Buy stocks driven by secular trends 7:22 a.m. July 10, 2012 - The Trading Deck
Thursday’s top gaining and declining stocks 4:54 p.m. June 28, 2012 - MarketWatch
Synta dives 30% on lung cancer study 11:21 a.m. June 28, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:44 p.m. Jan. 6, 2012 - Kate Gibson
Synta tumbles 14% on stock offering 12:47 p.m. Jan. 6, 2012 - Val Brickates Kennedy
Novavax grabs drug-stock spotlight 1:49 p.m. March 1, 2011 - Val Brickates Kennedy
Medicis, PDL lead drug stocks north 12:47 p.m. Feb. 28, 2011 - Val Brickates Kennedy
Synta shares jump on lung cancer drug update 11:41 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Synta rallies as drug stocks slip 1:33 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Synta rallies as drug stocks slip 11:05 a.m. Feb. 9, 2011 - Val Brickates Kennedy
Updates, advisories and surprises 7:31 p.m. Aug. 10, 2010 - MarketWatch
SciClone, Synta lead decliners 3:34 p.m. Aug. 10, 2010 - Val Brickates Kennedy
Synta falls on financial update 10:32 a.m. Aug. 10, 2010 - Val Brickates Kennedy
Javelin shares plunge on U.K. drug recall 4:09 p.m. May 24, 2010 - Val Brickates Kennedy
Big Pharma advances in broader market rally 3:35 p.m. May 10, 2010 - Val Brickates Kennedy
Drug stocks mixed; Angiotech climbs on FDA update 1:52 p.m. Oct. 10, 2007 - Val Brickates Kennedy
GlaxoSmithKline, Synta to develop melanoma treatment 9:00 a.m. Oct. 10, 2007 - Robert Daniel
Synta Pharma IPO falls to $9.42, below $10 price 3:27 p.m. Feb. 6, 2007 - Steve Gelsi
Synta Pharma IPO prices at $10, below $14-$16 range 12:19 p.m. Feb. 6, 2007 - Steve Gelsi
Short Interest is Piling Up in Synta (SNTA) Stock, Time to Panic? - Tale of the Tape 8:57 a.m. May 23, 2014 - Zacks.com
10-Q: SYNTA PHARMACEUTICALS CORP 6:18 a.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Speculative But Attractive Biotechs Insiders Are Buying 10:12 a.m. April 21, 2014 - Seeking Alpha
SNTA: Insiders Vs. Shorts 2:33 p.m. April 11, 2014 - TheStreet.com
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% - Tale of the Tape 8:44 a.m. March 21, 2014 - Zacks.com
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Synta Pharma up 26% premarket 8:20 a.m. March 20, 2014 - Seeking Alpha
SNTA: Synta Pharmaceuticals Soars on Breast Cancer Treatment News 7:12 a.m. March 20, 2014 - InvestorPlace.com
7 Stocks That Analysts Want You To Sell 7:41 a.m. March 16, 2014 - 247WallSt.com
Top Analyst Upgrades and Downgrades: AIG, GM, Rite Aid, Synta, Disney and More 7:34 a.m. March 12, 2014 - 247WallSt.com
Synta Pharmaceuticals' Management Discusses Q4 2013 Results - Earnings Call Transcript 2:01 p.m. March 11, 2014 - Seeking Alpha
Synta Pharmaceuticals Corp. Discusses Q3 2013 Results (Webcast) 9:55 a.m. March 11, 2014 - Seeking Alpha
10-K: SYNTA PHARMACEUTICALS CORP 6:09 a.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Weakness Seen in Synta Pharmaceuticals (SNTA): Stock Tumbles 13.5% - Tale of the Tape 9:54 a.m. March 6, 2014 - Zacks.com
Synta CEO resigns 5:19 p.m. March 3, 2014 - Seeking Alpha
2 $7 Speculative Biotechs That Are On The Move 10:26 a.m. Feb. 26, 2014 - Seeking Alpha
Synta Pharmaceuticals (SNTA) Catches Eye: Stock Rises 8.9% - Tale of the Tape 10:25 a.m. Feb. 25, 2014 - Zacks.com
Synta anti-cancer platform shows "proof of principle" 10:35 a.m. Feb. 24, 2014 - Seeking Alpha
Four Biotech Stocks Called to Double 9:34 a.m. Feb. 22, 2014 - 247WallSt.com
Two $5 Biotech Stocks Insiders Are Scooping Up 9:41 a.m. Feb. 10, 2014 - Seeking Alpha
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
Synta to Present at the Jefferies 2014 Global Healthcare Conference 8:02 a.m. May 29, 2014 - BusinessWire - BZX
Synta Announces Presentations at the 2014 American Society for Clinical Oncology (ASCO) Annual Meeting 8:04 a.m. May 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- Research on Alnylam Pharma, Regeneron Pharma, Cel-Sci, and Synta Pharma 10:15 a.m. May 13, 2014 - PR Newswire - PRF
Synta Announces Results From Final Analysis of the GALAXY-1 Trial of Ganetespib in NSCLC 7:04 a.m. May 8, 2014 - BusinessWire - BZX
Synta Reports First Quarter 2014 Financial Results and Provides Corporate Update 7:04 a.m. May 8, 2014 - BusinessWire - BZX
Synta to Host Conference Call and Webcast of First Quarter 2014 Financial Results on May 8, 2013 5:01 p.m. April 29, 2014 - BusinessWire - BZX
Synta Pharmaceuticals Enters Into Agreement to Sell $5.0 Million in Common Stock Directly to an Affiliate of Synta Board Member Bruce Kovner 8:03 a.m. April 14, 2014 - BusinessWire - BZX
Acquisitions, Scheduled Earnings Releases, Appointments, Clinical Trials, and Stock Movements - Analyst Notes on Baxter, AcelRx, Synta Pharmaceuticals, Spectranetics, and NuVasive 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Synta Announces Presentations at the 2014 Annual Meeting of the American Association of Cancer Research 7:31 a.m. April 7, 2014 - BusinessWire - BZX
Candidate Selection for Clinical Trials, Financial Results, and Patient Enrollments for Phase I Study - Analyst Notes on Synta, Ziopharm, Aastrom, Agios, and OncoMed 8:00 a.m. March 25, 2014 - PR Newswire - PRF
Synta Announces Positive Interim Results from the ENCHANT-1 Trial of Ganetespib in Metastatic Breast Cancer at the 9th European Breast Cancer Conference 5:45 a.m. March 20, 2014 - BusinessWire - BZX
Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology 8:25 a.m. March 19, 2014 - PR Newswire - PRF
Synta Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update 7:04 a.m. March 11, 2014 - BusinessWire - BZX
Synta and QuantumLeap Healthcare Collaborative Announce Selection of Ganetespib for I-SPY 2 TRIAL in Breast Cancer 7:02 a.m. March 11, 2014 - BusinessWire - BZX
Favorable Court Judgments, Stock Price Updates, and Upcoming Investors Conferences - Analyst Notes on Salix, Cerner, Hologic, Covance, and Synta 10:20 a.m. March 6, 2014 - PR Newswire - PRF
Synta Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director 5:02 p.m. March 3, 2014 - BusinessWire - BZX
Synta to Present on Hsp90-inhibitor Drug Conjugate Platform at the 12th International Congress on Targeted Anticancer Therapies 2:36 p.m. Feb. 28, 2014 - BusinessWire - BZX
Synta to Present at Upcoming Conferences 5:06 p.m. Feb. 27, 2014 - BusinessWire - BZX
Synta to Host Conference Call and Webcast of Fourth Quarter and Year-End 2013 Financial Results on March 11, 2014 5:06 p.m. Feb. 26, 2014 - BusinessWire - BZX
Buy stocks driven by secular trends 7:22 a.m. July 10, 2012 - The Trading Deck
Thursday’s top gaining and declining stocks 4:54 p.m. June 28, 2012 - MarketWatch
Synta dives 30% on lung cancer study 11:21 a.m. June 28, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:44 p.m. Jan. 6, 2012 - Kate Gibson
Synta tumbles 14% on stock offering 12:47 p.m. Jan. 6, 2012 - Val Brickates Kennedy
Novavax grabs drug-stock spotlight 1:49 p.m. March 1, 2011 - Val Brickates Kennedy
Medicis, PDL lead drug stocks north 12:47 p.m. Feb. 28, 2011 - Val Brickates Kennedy
Synta shares jump on lung cancer drug update 11:41 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Synta rallies as drug stocks slip 1:33 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Synta rallies as drug stocks slip 11:05 a.m. Feb. 9, 2011 - Val Brickates Kennedy
Updates, advisories and surprises 7:31 p.m. Aug. 10, 2010 - MarketWatch
SciClone, Synta lead decliners 3:34 p.m. Aug. 10, 2010 - Val Brickates Kennedy
Synta falls on financial update 10:32 a.m. Aug. 10, 2010 - Val Brickates Kennedy
Javelin shares plunge on U.K. drug recall 4:09 p.m. May 24, 2010 - Val Brickates Kennedy
Big Pharma advances in broader market rally 3:35 p.m. May 10, 2010 - Val Brickates Kennedy
Drug stocks mixed; Angiotech climbs on FDA update 1:52 p.m. Oct. 10, 2007 - Val Brickates Kennedy
GlaxoSmithKline, Synta to develop melanoma treatment 9:00 a.m. Oct. 10, 2007 - Robert Daniel
Synta Pharma IPO falls to $9.42, below $10 price 3:27 p.m. Feb. 6, 2007 - Steve Gelsi
Synta Pharma IPO prices at $10, below $14-$16 range 12:19 p.m. Feb. 6, 2007 - Steve Gelsi
Short Interest is Piling Up in Synta (SNTA) Stock, Time to Panic? - Tale of the Tape 8:57 a.m. May 23, 2014 - Zacks.com
10-Q: SYNTA PHARMACEUTICALS CORP 6:18 a.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Speculative But Attractive Biotechs Insiders Are Buying 10:12 a.m. April 21, 2014 - Seeking Alpha
SNTA: Insiders Vs. Shorts 2:33 p.m. April 11, 2014 - TheStreet.com
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% - Tale of the Tape 8:44 a.m. March 21, 2014 - Zacks.com
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Synta Pharma up 26% premarket 8:20 a.m. March 20, 2014 - Seeking Alpha
SNTA: Synta Pharmaceuticals Soars on Breast Cancer Treatment News 7:12 a.m. March 20, 2014 - InvestorPlace.com
7 Stocks That Analysts Want You To Sell 7:41 a.m. March 16, 2014 - 247WallSt.com
Top Analyst Upgrades and Downgrades: AIG, GM, Rite Aid, Synta, Disney and More 7:34 a.m. March 12, 2014 - 247WallSt.com
Synta Pharmaceuticals' Management Discusses Q4 2013 Results - Earnings Call Transcript 2:01 p.m. March 11, 2014 - Seeking Alpha
Synta Pharmaceuticals Corp. Discusses Q3 2013 Results (Webcast) 9:55 a.m. March 11, 2014 - Seeking Alpha
10-K: SYNTA PHARMACEUTICALS CORP 6:09 a.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Weakness Seen in Synta Pharmaceuticals (SNTA): Stock Tumbles 13.5% - Tale of the Tape 9:54 a.m. March 6, 2014 - Zacks.com
Synta CEO resigns 5:19 p.m. March 3, 2014 - Seeking Alpha
2 $7 Speculative Biotechs That Are On The Move 10:26 a.m. Feb. 26, 2014 - Seeking Alpha
Synta Pharmaceuticals (SNTA) Catches Eye: Stock Rises 8.9% - Tale of the Tape 10:25 a.m. Feb. 25, 2014 - Zacks.com
Synta anti-cancer platform shows "proof of principle" 10:35 a.m. Feb. 24, 2014 - Seeking Alpha
Four Biotech Stocks Called to Double 9:34 a.m. Feb. 22, 2014 - 247WallSt.com
Two $5 Biotech Stocks Insiders Are Scooping Up 9:41 a.m. Feb. 10, 2014 - Seeking Alpha
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
Synta to Present at the Jefferies 2014 Global Healthcare Conference 8:02 a.m. May 29, 2014 - BusinessWire - BZX
Synta Announces Presentations at the 2014 American Society for Clinical Oncology (ASCO) Annual Meeting 8:04 a.m. May 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- Research on Alnylam Pharma, Regeneron Pharma, Cel-Sci, and Synta Pharma 10:15 a.m. May 13, 2014 - PR Newswire - PRF
Synta Announces Results From Final Analysis of the GALAXY-1 Trial of Ganetespib in NSCLC 7:04 a.m. May 8, 2014 - BusinessWire - BZX
Synta Reports First Quarter 2014 Financial Results and Provides Corporate Update 7:04 a.m. May 8, 2014 - BusinessWire - BZX
Synta to Host Conference Call and Webcast of First Quarter 2014 Financial Results on May 8, 2013 5:01 p.m. April 29, 2014 - BusinessWire - BZX
Synta Pharmaceuticals Enters Into Agreement to Sell $5.0 Million in Common Stock Directly to an Affiliate of Synta Board Member Bruce Kovner 8:03 a.m. April 14, 2014 - BusinessWire - BZX
Acquisitions, Scheduled Earnings Releases, Appointments, Clinical Trials, and Stock Movements - Analyst Notes on Baxter, AcelRx, Synta Pharmaceuticals, Spectranetics, and NuVasive 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Synta Announces Presentations at the 2014 Annual Meeting of the American Association of Cancer Research 7:31 a.m. April 7, 2014 - BusinessWire - BZX
Candidate Selection for Clinical Trials, Financial Results, and Patient Enrollments for Phase I Study - Analyst Notes on Synta, Ziopharm, Aastrom, Agios, and OncoMed 8:00 a.m. March 25, 2014 - PR Newswire - PRF
Synta Announces Positive Interim Results from the ENCHANT-1 Trial of Ganetespib in Metastatic Breast Cancer at the 9th European Breast Cancer Conference 5:45 a.m. March 20, 2014 - BusinessWire - BZX
Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology 8:25 a.m. March 19, 2014 - PR Newswire - PRF
Synta Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update 7:04 a.m. March 11, 2014 - BusinessWire - BZX
Synta and QuantumLeap Healthcare Collaborative Announce Selection of Ganetespib for I-SPY 2 TRIAL in Breast Cancer 7:02 a.m. March 11, 2014 - BusinessWire - BZX
Favorable Court Judgments, Stock Price Updates, and Upcoming Investors Conferences - Analyst Notes on Salix, Cerner, Hologic, Covance, and Synta 10:20 a.m. March 6, 2014 - PR Newswire - PRF
Synta Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director 5:02 p.m. March 3, 2014 - BusinessWire - BZX
Synta to Present on Hsp90-inhibitor Drug Conjugate Platform at the 12th International Congress on Targeted Anticancer Therapies 2:36 p.m. Feb. 28, 2014 - BusinessWire - BZX
Synta to Present at Upcoming Conferences 5:06 p.m. Feb. 27, 2014 - BusinessWire - BZX
Synta to Host Conference Call and Webcast of Fourth Quarter and Year-End 2013 Financial Results on March 11, 2014 5:06 p.m. Feb. 26, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼